Inventor
NABET BEHNAM
US5 patents
Patents
5 patentsUS11311609B2Apr 26, 2022
Regulating chimeric antigen receptors
DANA FARBER CANCER INST INC6 citations71
US11046954B2Jun 29, 2021
Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses
DANA FARBER CANCER INST INC2 citations71
US11293023B2Apr 5, 2022
Tunable endogenous protein degradation
DANA FARBER CANCER INST INC0 citations61
US12023385B2Jul 2, 2024
Tunable endogenous protein degradation with heterobifunctional compounds
DANA FARBER CANCER INST INC0 citations49
US12365696B2Jul 22, 2025
Small-molecule focal adhesion kinase (FAK) inhibitors
DANA FARBER CANCER INST INC0 citations44